This post is a list of short ideas, sorted by market cap. The borrow on these stocks is generally 10% or lower. Some of the more interesting shorts are AMD, PVG, TMR.TO, CRC, Chinese reverse mergers, and CGIP.
Valeant has a reputation for significantly increasing the prices of its drugs. The truth is a little more complex than that.
Through its so-called “specialty pharmacy” channel, Valeant engages in an unusual practice of sending drugs to consumers without a guarantee of receiving insurance reimbursement from private payors. If the reimbursement claim is ultimately denied, Valeant ends up selling a drug at firesale prices.